All News

BougeRV Arch launches new Max 270° bendable fiberglass Solar Panel with technological breakthrough

LOS ANGELES, Dec. 13, 2023 /PRNewswire/ -- BougeRV, a world-class leading provider of outdoor appliances and the ultimate one-stop solution for all outdoor needs...

Bahamian Prime Minister lays climate truth on the line in 17th annual McCarthy Lecture

Philip Davis urged Bennies and Johnnies, which include 60 current students and more than 1,600 alumni, to strengthen their legacy and commit to helping...

Hypertrophic Cardiomyopathy Pipeline Research Report 2023 Featuring Cytokinetics, Imbria, Bristol-Myers Squibb, Tenaya Therapeutics, Lexeo Therapeutics, and BioMarin

DUBLIN, Dec. 13, 2023 /PRNewswire/ -- The "Hypertrophic Cardiomyopathy - Pipeline Insight, 2023" clinical trials has been added to  ResearchAndMarkets.com's offering. This  report provides comprehensive insights...

O'BRIEN: REVOKE PNTR FOR CHINA

WASHINGTON, Dec. 13, 2023 /PRNewswire/ -- The following is a statement from Teamsters General President Sean M. O'Brien regarding the recent report from the...

EQUINOX ANNOUNCES HEALTH ADVISORY BOARD

NEW YORK, Dec. 13, 2023 /PRNewswire/ -- Equinox, the category leader of high-performance luxury lifestyle, today announced a new Health Advisory Board that will...

Revolutionizing the Road Ahead: Motive Retail Appoints Phil Taylor as President to Lead Automotive Integration Evolution

LONGMONT, Colo., Dec. 13, 2023 /PRNewswire/ -- Motive Retail, a leading integrator specializing in modernizing the automotive retail experience, is pleased to announce the...

New Research Insights on Artificial Intelligence from Americans Age 55+

EVANSTON, Ill., Dec. 13, 2023 /PRNewswire/ -- The majority of today's Americans age 55+ have positive views on artificial intelligence, according to new findings...

Inhibitor Therapeutics, Inc. Exclusive License with Johns Hopkins University

A critical milestone completed on the mission path of commercializing Itraconazole in numerous oncology indications. TAMPA, Fla., Dec. 13, 2023 /PRNewswire/ -- Inhibitor Therapeutics, Inc....

Latest articles